From October 1, 2022 to October 25, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 36,138,098 shares, representing 1.94% for CNY 425.67 million under the buyback announced on April 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.698 CNY | +1.10% | -1.08% | +4.85% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.85% | 3.86B | |
+26.60% | 76.19B | |
-1.98% | 24.06B | |
+10.02% | 8.83B | |
+10.22% | 8.51B | |
-22.96% | 7.72B | |
+12.33% | 5.2B | |
+2.96% | 4.18B | |
-5.61% | 4.01B | |
+1.01% | 3.09B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.